Fundamental index

000153.SZ Anhui Fengyuan Pharmaceutical Co., Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · CN · as of 2026-09-08

E
Fundamental score
31.39

Reasons

  • Valuation 66: PE n/a, EV/EBITDA n/a, FCF yield -1.3%
  • Quality 25: ROE 4.6%, ROIC n/a, net margin 2.6%
  • Balance 3: debt/equity n/a, current ratio 0.90, Altman Z 1.47

Risk flags

low Altman Z 1.47negative FCF/share -0.07

Component scores

Quality25
Growth50
Balance3
Valuation66
Cash flow1

Key metrics

ROE
4.6% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
ROICn/a
Net margin
2.6% higher is usually better
-10%35%+
weak < 0%ok >= 10%strong >= 20%
Revenue growthn/a
Debt / equityn/a
Current ratio
0.90 above 1 is generally healthier
03+
risk < 1.0ok >= 1.0strong >= 2.0
Altman Z-score
1.47 higher usually means lower distress risk
04+
distress < 1.8grey 1.8-3.0safer > 3.0
PE ration/a
EV / EBITDAn/a
FCF yield
-1.3% higher cash-flow yield is usually better
-5%15%+
weak < 0%ok >= 3%strong >= 8%

Revenue

4.28B 3.01B 3.01B 3.24B 3.32B 3.65B 4.00B 4.28B 4.28B 3.86B 2018 2019 2020 2022 2023 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: revenue values.

Net income

160.83M 60.93M 60.93M 80.92M 103.72M 122.98M 154.43M 159.29M 160.83M 99.42M 2018 2019 2020 2022 2023 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: net income values.

Free cash flow

358.23M -101.31M 148.96M -79.40M 102.01M 80.52M 358.23M 102.64M -17.78M -101.31M 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: free cash flow values.

Growth metrics

16.9% -10.0% 16.9% 7.5% 2.6% 10.0% 9.6% 6.8% 0.2% -10.0% 2018 2019 2020 2021 2022 2023 2024 2025

X-axis: fiscal years from cached FMP annual statement data. Y-axis: growth metrics values.

Abbreviations and definitions

ROE
ROE measures how much net profit a company generates from shareholders' equity.
ROIC
ROIC compares operating profit after tax with the capital invested in the business.
Net margin
Net margin shows how much net profit remains from revenue.
Revenue growth
Revenue growth measures how sales changed versus the comparable prior period.
Debt / equity
Debt to equity compares company debt with shareholders' equity.
Current ratio
Current ratio compares short-term assets with short-term liabilities.
Altman Z-score
Altman Z-score is a model estimating bankruptcy risk from financial ratios.
PE ratio
PE compares market price with earnings per share.
EV / EBITDA
EV/EBITDA compares total company value with operating earnings before depreciation and amortization.
FCF yield
FCF yield compares free cash flow with market value.
Revenue
Revenue is the total amount generated from selling goods or services before expenses.
Net income
Net income is profit after operating costs, interest, taxes and other expenses.
Free cash flow
Free cash flow is cash left after operating cash flow covers capital expenditures.
Growth metrics
Growth metrics summarize changes in revenue, profit or EPS versus a prior period.
EPS
EPS is net income allocated to each share.
EBITDA
EBITDA is earnings before interest, taxes, depreciation and amortization.
TTM
TTM is a rolling last-12-month view instead of one fiscal year.

This page is an automated factual summary of cached FMP data, not investment advice. Always verify source filings and liquidity before making decisions.